Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) Gross Margin (2009 - 2026)

Updated

Bristol Myers Squibb (BMY) posted Gross Margin of 68.28% for Q3 2026, down 3.62 percentage points from 71.89% a year earlier and down 3.00 percentage points from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Gross Margin (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Gross Margin at Bristol Myers Squibb was 69.24%, down 0.26 percentage points year-over-year; for FY2025, it came in at 71.08%, unchanged from FY2024.

  • Annual Gross Margin shows a five-year change of -1.23 percentage points (FY2020 to FY2025).
  • In prior years, Bristol Myers Squibb's Gross Margin was 71.08% in FY2024 (-5.16 pp), 76.24% in FY2023 (-1.80 pp), 78.04% in FY2022 (-0.53 pp) and 78.57% in FY2021 (+6.26 pp).
  • Quarterly Gross Margin has run from a low of 61.01% in Q4 2024 to a high of 80.34% in Q4 2021 over five years.
  • On a year-over-year basis, Gross Margin has declined in each of the last three quarters, with an average year-over-year change of -2.84 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Gross Margin in the past five years was Q4 2021, with a gain of 6.63 percentage points; the weakest was Q4 2024, with a drop of 15.07 percentage points.
  • According to Business Quant data, Gross Margin for the three prior quarters was 71.28% (Q2 2026), 70.22% (Q1 2026) and 67.23% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 83.88%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 68.12%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 75.38%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 72.95%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 88.03%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 73.10%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 81.07%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 75.71%
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn 68.28%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 68.28%
Jun 30, 2026 71.28%
Mar 31, 2026 70.22%
Dec 31, 2025 67.23%
Sep 30, 2025 71.89%
Jun 30, 2025 72.52%
Mar 31, 2025 72.92%
Dec 31, 2024 61.01%
Sep 30, 2024 75.13%
Jun 30, 2024 73.22%
Mar 31, 2024 75.29%
Dec 31, 2023 76.08%
Sep 30, 2023 77.15%
Jun 30, 2023 74.38%
Mar 31, 2023 77.37%
Dec 31, 2022 77.27%
Sep 30, 2022 79.02%
Jun 30, 2022 77.12%
Mar 31, 2022 78.79%
Dec 31, 2021 80.34%
API Access

Bristol Myers Squibb Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=BMY&period=max&api_key=YOUR_API_KEY